The autophagy receptor SQSTM1/p62 mediates anti-inflammatory actions of the selective NR3C1/glucocorticoid receptor modulator compound A (CpdA) in macrophages

Glucocorticoids are widely used to treat inflammatory disorders; however, prolonged use of glucocorticoids results in side effects including osteoporosis, diabetes and obesity. Compound A (CpdA), identified as a selective NR3C1/glucocorticoid receptor (nuclear receptor subfamily 3, group C, member 1...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Autophagy
Autors principals: Mylka, Viacheslav, Deckers, Julie, Ratman, Dariusz, De Cauwer, Lode, Thommis, Jonathan, De Rycke, Riet, Impens, Francis, Libert, Claude, Tavernier, Jan, Vanden Berghe, Wim, Gevaert, Kris, De Bosscher, Karolien
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2018
Matèries:
Research Paper - Basic Science
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6984772/
https://ncbi.nlm.nih.gov/pubmed/30215534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15548627.2018.1495681
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars